Monthly Archives: May 2016

AGAH Meeting, Berlin

Posted On 26-May-2016 by Steffan Stringer

AGAH, the German Association for Applied Human Pharmacology, held its 25th Annual Meeting on 21-22 April in Berlin, which focused on the topic “Exploratory drug development in immunological therapy”. The first day’s sessions covered a variety of immunological targets inherently … Continue reading →

Comments Off on AGAH Meeting, Berlin

Discount for AHPPI members at ACCP Meeting in Bethesda, MD, Sep-2016

Posted On 24-May-2016 by Steffan Stringer

Registration is open for the 2016 Annual Meeting of the American College of Clinical Pharmacology (ACCP). The meeting runs from 25th – 27th September at the Bethesda N Marriott Hotel & Conference Ctr in Bethesda, MD. The title of this year’s … Continue reading →

Comments Off on Discount for AHPPI members at ACCP Meeting in Bethesda, MD, Sep-2016

EMA stakeholder activity – User Acceptance Testing of new EU portal

Posted On 12-May-2016 by Steffan Stringer

Q1 2016 saw the User Acceptance Testing of the new EU portal/Clinical Trial Application system begin. BioKinetic Europe, Niche Science & Technology and Richmond Pharmacology, all of whom have a network of active members in AHPPI are registered testers on behalf … Continue reading →

Comments Off on EMA stakeholder activity – User Acceptance Testing of new EU portal

Evening with the Experts

Posted On 9-May-2016 by Steffan Stringer

This year we shall be offering a new benefit for members. We are looking to host two hour meetings held in the evening (e.g. 18:00 to 20:00) up to four times a year. The venues would probably be a Phase I unit, … Continue reading →

Comments Off on Evening with the Experts

EUFEMED Conference, May 2017, London

Posted On 9-May-2016 by Steffan Stringer

Save the date! The European Federation for Exploratory Medicines Development (EUFEMED) has scheduled it’s biennial conference for 17-19 May 2017 in London. The AHPPI will be organising the meeting and members will be entitled to a discounted rate. The programme is … Continue reading →

Comments Off on EUFEMED Conference, May 2017, London

Club Phase 1 meeting, Paris

Posted On 4-May-2016 by Steffan Stringer

Club Phase 1, a group representing early clinical development stakeholders in France, held their 16th Annual Meeting in Paris on 22nd March. Topics ranged from dealing with immunogenicity to Drug Drug Interactions and a session led by a Biotrial representative … Continue reading →

Comments Off on Club Phase 1 meeting, Paris